Kureha Chemical Industry’s Proprietary Anti-Chronic Renal Failure Agent KREMEZIN Now Available In Korea

Tokyo (JCNN) - Kureha Chemical Industry (TSE: 4023) has announced that KREMEZIN, its proprietary ethical drug used in the treatment of chronic renal failure (CRF), will be finally launched in Korea on February 1.